Joshua Meeks

The FDA approves the signatera ctDNA assay for muscle invasive bladder cancer patients post surgery. This is based on the results of Imvigor011 study (atezo vs placebo in ctDNA positives, surveillance for the ctDNA negatives). It opens a new chapter for personalised therapy in urothelial cancer. Focusing on early treatment for those patients that need it and sparing those at lower risk potentially harmful treatment makes sense. ‘It is the first companion diagnostic approval in the field of blood-based MRD.’ natera.com/company/news/s…

@eugene_pietzak incrediblely elegant P2 on bcg + Pembro in VHR T1. 92% response, 94% RC- free. 1 early death and 21% iAEs. n=37 but great job to consider risk - based strategy. #AUA26

Very reasonable responses - Legend on its way

Congratulations to the newly awarded 2026 National Residency Abstract Olympics winners! 🏆 @CleClinicUro @NM_Urology @WCMUrology #AUA26

Small numbers but improved cystectomy free survival and lower rates in bcg+durva arms of Potomac. Seems less bcg unresponsive. This may be the piece that matters #bladdercancer. #AUA26

Perioperative durvalumab (12 months) with neoadjuvant EV (3 cycles) shows ‘statistically significant and clinically meaningful’ improved EFS and OS vs cystectomy alone in MIBC (like KN905 (EVP cs cystectomy)). The shorter period of EV is the major difference in trial designs. Details of efficacy and toxicity will be important. The 3rd arm, where tremelimumab was added as a triplet, did not hit OS at this stage. astrazeneca.com/media-centre/p… @OncoAlert

Urologic Oncologist's fifteen minutes of fame

Wow

@USC_Urology @siadaneshmand Big congrats and well deserved.

Congrats to Sia Daneshmand, MD, (@siadaneshmand), on his election to the American Association of Genitourinary Surgeons (AAGUS), one of urology’s most prestigious, invitation-only societies. A well-deserved recognition of his impact in academic urology and surgical innovation.

We are very proud of our editor, Jeremy Teoh, who has been invited to deliver the prestigious John K. Lattimer Lecture at the AUA Annual Meeting 2026. The Lattimer Lecture, first established in 1977, recognises new innovations and practices with the potential to revolutionise urology and medicine more broadly. Previous awardees include distinguished leaders in the field such as Vipul Patel, Ralph Clayman, Glenn Preminger, Curtis Nickel, and Ash Tewari. Jeremy shared that he feels deeply honoured to receive this recognition as an Asian researcher and warmly invites colleagues and friends to attend the lecture at Hall D at 1:00 PM on 15 May 2026. A group photo will take place outside the hall after the lecture at approximately 1:30 PM. Congratulations, @jteoh_hk, on this outstanding achievement! @uroweb @mroupret @GPloussard @Ric_Campi @CaPsurvivorship @LauraMarandino @RenuEapen @Ecastromarcos @OncoAlert @Sciencedirect @AmericanUrological

For 15+ years, our work has shown that histone-modifying enzymes do more than just their catalytic jobs. They also have important non-catalytic roles. Dr. Zibo Zhao just published a great review on COMPASS family enhancer monomethylases and discusses how their loss creates new druggable vulnerabilities. nature.com/articles/s4156… Her findings are now in the clinic for treatment of cancers bearing MLL3/4-COMPASS mutations Fingers crossed! @NU_BMG_SQE @NUFeinbergMed @theNASciences @theNAMedicine @CellPressNews @ScienceMagazine @Nature @NatureCancer @MolecularCell @zhao_zibo

It's #AUA2026, and we are very excited to share our latest paper- a collaboration with @Cui_Lab investigating macrophage-T cell interactions by sc-RNA-Seq in adjacent-normal stroma of BCG-treated bladder and PBMCs #BDRhapsody @jclinicalinvest jci.org/articles/view/…

We are pleased to announce the appointment of Joseph Liao, MD, as the next Chair of the Department of Urology, effective August 1. Read the full announcement from Dean Lloyd Minor: urology.stanford.edu/news/04-24-202… @liaojoe1 @StanfordMed @AmerUrological

@

TURBT is one of the most impt surgical skills in managing #bladdercancer 2026 course was another big success. Thank you @olympusamerica for your support Incredible group of residents fellows and attendings there this year. Thx @JoshMeeks and John Sfakianos for helping teach

Another great course. Thanks to all our attendees, faculty and staff. @Olympus_Corp

@LauraBukavinaMD @Olympus_Corp organized the course. Would love to have more trainees.

@JoshMeeks This would be great for our residents , how did you arrange this ? With Olympus or this is institutional?

Olympus TURBT Course flex cystoscope and biopsy

More views of these great bladder models

Bladder neck

Some more dome tumors